Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Refractory (Phase 1)
Astrocytoma (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Verrucous (Phase 2)
Choroid Plexus Neoplasms (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Craniopharyngioma (Phase 1)
Ependymoma (Phase 1)
Glioma (Phase 1)
Graft vs Host Disease (Phase 2)
Hodgkin Disease (Phase 1)
Leukemia (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Monocytic, Acute (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Myeloid, Chronic-Phase (Phase 1)
Leukemia, Myelomonocytic, Acute (Phase 1)
Liver Neoplasms (Phase 2)
Lymphoma (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphomatoid Granulomatosis (Phase 1)
Medulloblastoma (Phase 1)
Melanoma (Phase 2)
Meningioma (Phase 1)
Myelodysplastic Syndromes (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Neuroectodermal Tumors (Phase 1)
Ovarian Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Spinal Cord Neoplasms (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue